Moreover, there is a lack of literature evaluating liver fibrosis among AIS patients treated with intravenous tissue plasminogen activator (IV tPA) therapy, the mainstay of treatment for AIS [8]. The gene discussed is PLAT; the disease is Hepatic fibrosis.